Navigation Links
Cephalon Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015
Date:8/22/2011

a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd. in October 2011 and, in addition, may include statements regarding anticipated scientific progress on its research programs, development of potential pharmaceutical products, interpretation of clinical results, prospects for regulatory approval, manufacturing development and capabilities, market prospects for its products, sales and earnings guidance, and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing Cephalon such as those set forth in its reports on Form 8-K, 10-Q and 10-K filed with the SEC. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Cephalon does not intend to update publicly any forward-looking statement, except as required by law. The Private Securities Litigation Reform Act of 1995 permits this discussion.Cephalon:Investor Contacts:Media Contacts:Chip Merritt

(610) 738-6376

cmerritt@cephalon.comFritz Bittenbender

Cell: (610) 457-7041

Office: (610) 883-5855

fbittenb@cephalon.comJoseph Marczely

(610) 883-5894

jmarczely@cephalon.comNatalie de Vane

Cell: (610) 999-8756

Office: (610) 727-6536

'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Receives FDA Approval for Risk Evaluation and Mitigation Strategy for FENTORA and ACTIQ
2. Cephalon Shareholders Approve Acquisition by Teva
3. Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction
4. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
5. Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors
6. Cephalon Lodges Bidders Statement for A$167 Million Offer for ChemGenex Pharmaceuticals
7. Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
8. Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
9. Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited
10. Cephalon Wins FENTORA Patent Suit Against Watson
11. Cephalon Announces Definitive Agreement to Acquire Gemin X
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... --  Royal Philips  (NYSE: PHG, AEX: PHIA) today announced ... system designed to enable global hospitals and health systems ... cost pressures. Making its debut at the  European Society ... this week, Affiniti provides innovative technology to ... deliver high quality patient care. "Affiniti ...
(Date:8/29/2014)... Aug. 29, 2014 The clinical and medical ... the difference between a product,s success or failure. Despite ... stratify KOL targets – and then to coordinate activities ... strong relationships upon which successful KOL engagement rests. ... have identified internal inconsistencies in their KOL management systems ...
(Date:8/29/2014)... -- Pomerantz LLP has filed a class action lawsuit ... EDAP ) and certain of its officers.  The ... District of New York , and ... consisting of all persons or entities who purchased EDAP ... inclusive (the "Class Period"). This class action seeks to recover ...
Breaking Medicine Technology:Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4Implementing a Strategic Thought Leader Management & Engagement System 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3
... CVD ) today reported results for its third ... of $0.49 per diluted share.  Included in results is a ... write-down of preclinical assets, partially offset by a gain of ... the quarter. Excluding these items, earnings per diluted share were ...
... Nov. 3, 2010 The American College of Radiology (ACR) ... ( MCR5 ) educational CD-ROM free of charge to ... State. Mammography Case Review ( ... and improve their skills regarding the detection of cancers and ...
Cached Medicine Technology:Covance Reports Third Quarter Financial Results and Takes Actions to Strengthen Future Performance 2Covance Reports Third Quarter Financial Results and Takes Actions to Strengthen Future Performance 3Covance Reports Third Quarter Financial Results and Takes Actions to Strengthen Future Performance 4Covance Reports Third Quarter Financial Results and Takes Actions to Strengthen Future Performance 5Covance Reports Third Quarter Financial Results and Takes Actions to Strengthen Future Performance 6Covance Reports Third Quarter Financial Results and Takes Actions to Strengthen Future Performance 7Covance Reports Third Quarter Financial Results and Takes Actions to Strengthen Future Performance 8Covance Reports Third Quarter Financial Results and Takes Actions to Strengthen Future Performance 9Covance Reports Third Quarter Financial Results and Takes Actions to Strengthen Future Performance 10Covance Reports Third Quarter Financial Results and Takes Actions to Strengthen Future Performance 11Covance Reports Third Quarter Financial Results and Takes Actions to Strengthen Future Performance 12Covance Reports Third Quarter Financial Results and Takes Actions to Strengthen Future Performance 13ACR Distributes Free High-Tech Mammography Education Tool to NY Facilities 2
(Date:8/30/2014)... A new method to predict the optimal number ... at ESC Congress today by Dr Benjamin Dahan from ... AEDs located in public places for optimal prevention of ... said: "Out of hospital cardiac arrest is a major ... 50 and 100 per 100 000 in the general ...
(Date:8/30/2014)... Sunday 31 August 2014: Local anaesthetic is as safe ... general anaesthetic, according to results of the FRANCE 2 ... Chopard from France. , Dr Chopard said: "Numerous studies ... for patients with severe symptomatic aortic stenosis who are ... aortic valve replacement. The number of TAVI procedures in ...
(Date:8/30/2014)... A retrievable and repositionable transcatheter aortic valve is ... according to research presented at ESC Congress 2014 ... direct flow medical (DFM) transcatheter aortic valve has ... the potential to improve transcatheter aortic valve implantation ... , Dr Pyxaras said: "TAVI is well established ...
(Date:8/30/2014)... 31 August 2014: A new batteryless cardiac pacemaker ... heart motion was presented at ESC Congress 2014 ... device does not require battery replacement. , Mr ... Group at ARTORG, University of Bern, Switzerland, said: ... implants. Once they reach a critically low energy ...
(Date:8/30/2014)... 31, 2014 Walking-Canes.Net has released ... a mobility device can help in making gait problems easier. ... download from the website that contains all of the news ... site. , The articles deal with diseases that make walking ... walking cane can help in making life easier for the ...
Breaking Medicine News(10 mins):Health News:New method predicts optimal number and location of AEDs 2Health News:Local anesthetic for TAVI as safe and effective as general anesthetic 2Health News:Retrievable transcatheter aortic valve effective and safe in real world setting 2Health News:Batteryless cardiac pacemaker is based on automatic wristwatch 2Health News:Information Articles on Gait Problems from Walking-Canes.Net 2
... earlier use of antibiotics for blood infection , , TUESDAY, ... in Spain to promote appropriate care for severe sepsis ... adherence and a lower rate of sepsis deaths in ... accounts for one in five admissions to intensive care ...
... giving again, experts warn , , TUESDAY, May 20 (HealthDay News) ... time of decreasing blood donations, a new study shows that ... 17-year-olds, are more likely to bruise, faint or experience other ... of young donors may be less likely to give in ...
... A new 12-week study2examined safety and efficacy ... (budesonide/formoterol fumarate dehydrate) Inhalation Aerosol,2 in treating mild ... to 15 years old2 who were previously treated ... study included efficacy assessments of nighttime symptoms, nighttime ...
... Vista Partners announced today that,it has initiated ... ).,Ross Silver, Director of Research of Vista Partners ... encouraging,clinical and preclinical data to date. Cethrin would ... to Cethrin, Alseres has a molecular,imaging program in ...
... May 20 Ambulatory Services of,America, Inc. announced ... fourth,joint venture to provide outpatient radiation oncology services. ... Cancer Center, LP and ASA,s,subsidiary, Radiation Oncology Services ... operate a radiation therapy facility in Denton, Texas ...
... the thought of baring your,pasty, dry, winter skin makes ... from the International SPA Association have you,covered with some ... in,time for summer! There,s no doubt you,ll be turning ... ISPA member spa prepping for the hot months,ahead., ...
Cached Medicine News:Health News:Educational Drive Cut Death Rate From Sepsis 2Health News:Teen Blood Donors More Prone to Complications 2Health News:Teen Blood Donors More Prone to Complications 3Health News:Study analyzed SYMBICORT in children with persistent asthma 2Health News:Study analyzed SYMBICORT in children with persistent asthma 3Health News:Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) 2Health News:Ambulatory Services of America, Inc. Announces Joint Venture With Denton Cancer Center, LP 2Health News:10 Ways to Stay Cool This Summer With Hot Spa Products and Treatments 2Health News:10 Ways to Stay Cool This Summer With Hot Spa Products and Treatments 3
... is based on SIREMOBIL Iso-C, the first ... the intra-operative 3D-Mode, the 3D-dataset is immediately ... orbital movement. This allows the surgeon to ... during the procedure. This 3D capability is ...
... Humphrey Field Analyzer II-i series is a ... the patient's visual field. ,By using SITA, ... is reduced by up to 70%. ,A ... ergonomic design to increase patient comfort while ...
... an innovative device designed to be a ... abdominal aortic aneurysms (AAA). It is constructed ... an outer self-expanding Nitinol support structure to ... The function of the endoprosthesis is to ...
... a cast from an arm or leg can ... cut or burned by the cast saw blade. ... remove any cast with confidence. This innovative, cut-resistant ... burns from the cast saw and can be ...
Medicine Products: